Justify bioequivalent data: CDSCO Panel Tells Sun Pharma on Mirabegron Extended-release Tablets Dr. Divya Colin8 March 2024 6:00 PM ISTNew Delhi: After reviewing the bioequivalence (BE) report of Mirabegron extended-release Tablets 50 mg presented by drug major Sun Pharma, the Subject...
Chalk powder instead of medicines: Telangana drug controller issues alert against drugs by Meg Lifesciences Ruchika Sharma7 March 2024 4:31 PM ISTTelangana: In a significant move to curb the menace of falsified drugs, the Drugs Control Administration, Telangana, has issued a Spurious Drug Alert...
CDSCO Panel rejects Torrent proposal To Waive BE Study of FDC Gabapentin plus Duloxetine Dr. Divya Colin6 March 2024 6:00 PM ISTNew Delhi: Rejecting the proposal for the bioequivalence (BE) study waiver, the Subject Expert Committee (SEC) functional under the Central Drug...
Submit Post Marketing Safety Data of Indians: CDSCO Panel Tells Novo Nordisk on Semaglutide Warning Statement Dr. Divya Colin5 March 2024 6:00 PM ISTNew Delhi: In response to the proposal presented by the drug major Novo Nordisk for the amendment in the warning statement for the antidiabetic drug...
Dr. Reddy's gets CDSCO panel Nod To market Omeprazole Delayed-release orally disintegrating tablets Dr. Divya Colin4 March 2024 6:00 PM ISTNew Delhi: In a significant development, the drug major Dr. Reddy's Laboratories has got a go-ahead from the Subject Expert Committee (SEC) functional...
NPPA Fixes Retail Prices of 69 Formulations, Details Dr. Divya Colin3 March 2024 6:00 PM ISTNew Delhi: Through a recent notification, the National Pharmaceutical Pricing Authority (NPPA) has fixed the retail price of the 69 formulations...
NPPA Fixes Ceiling Price Of 6 Scheduled Formulations, Details Susmita Roy2 March 2024 6:00 PM ISTNew Delhi: Through a recent notification, the National Pharmaceutical Pricing Authority (NPPA) has fixed the ceiling price of 6 scheduled formulations...
Sanofi gets CDSCO Panel nod to study Antidiabetic Drug Insulin Glargine and Lixisenatide Injection Dr. Divya Colin1 March 2024 6:00 PM ISTNew Delhi: The drug major Sanofi has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Eli Lilly gets CDSCO Panel Nod to Import, Market Antidiabetic Drug Tirzepatide solution for injection Single dose vial Dr. Divya Colin29 Feb 2024 6:00 PM ISTNew Delhi: The drug major Eli Lilly has got a go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Glenmark Gets CDSCO Panel Nod to Study ISB 2001 in Multiple Myeloma Dr. Divya Colin28 Feb 2024 6:00 PM ISTNew Delhi: The drug major Glenmark has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Synokem Pharma Gets CDSCO Panel Nod To Study Antidiabetic FDC Dr. Divya Colin27 Feb 2024 6:00 PM ISTNew Delhi: The drug major Synokem Pharmaceutical has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard...
Sanofi Gets CDSCO Panel Nod to Study COPD drug Itepekimab Dr. Divya Colin26 Feb 2024 6:00 PM ISTNew Delhi: The drug major Sanofi has got a go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
